| Term | Count | % | | DRUG INEFFECTIVE | 4035 | 9.17% |
| TREATMENT FAILURE | 3070 | 6.98% |
| OCULAR HYPERAEMIA | 2304 | 5.24% |
| EYE IRRITATION | 1797 | 4.08% |
| MADAROSIS | 1379 | 3.13% |
| EYE PRURITUS | 1307 | 2.97% |
| ERYTHEMA OF EYELID | 1007 | 2.29% |
| EYE PAIN | 886 | 2.01% |
| HYPERSENSITIVITY | 845 | 1.92% |
| VISION BLURRED | 814 | 1.85% |
| INTRAOCULAR PRESSURE INCREASED | 706 | 1.60% |
| FATIGUE | 677 | 1.54% |
| OFF LABEL USE | 675 | 1.53% |
| HEADACHE | 643 | 1.46% |
| DRY EYE | 637 | 1.45% |
| EYE SWELLING | 637 | 1.45% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 580 | 1.32% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.23% |
| DYSPNOEA | 529 | 1.20% |
| EYELIDS PRURITUS | 529 | 1.20% |
| DIZZINESS | 507 | 1.15% |
| ERYTHEMA | 505 | 1.15% |
| NAUSEA | 487 | 1.11% |
| INCORRECT DOSE ADMINISTERED | 486 | 1.10% |
| SKIN HYPERPIGMENTATION | 480 | 1.09% |
| DIARRHOEA | 476 | 1.08% |
| FALL | 447 | 1.02% |
| VISUAL IMPAIRMENT | 447 | 1.02% |
| ASTHENIA | 432 | 0.98% |
| EYELID OEDEMA | 419 | 0.95% |
| PRURITUS | 412 | 0.94% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.92% |
| PAIN | 385 | 0.88% |
| LACRIMATION INCREASED | 371 | 0.84% |
| EYELID IRRITATION | 367 | 0.83% |
| DEATH | 366 | 0.83% |
| RASH | 342 | 0.78% |
| PRODUCT DOSE OMISSION ISSUE | 340 | 0.77% |
| CATARACT | 328 | 0.75% |
| GLAUCOMA | 317 | 0.72% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 316 | 0.72% |
| MALAISE | 307 | 0.70% |
| EYE DISCHARGE | 301 | 0.68% |
| THERAPEUTIC RESPONSE DECREASED | 300 | 0.68% |
| GROWTH OF EYELASHES | 294 | 0.67% |
| SKIN DISCOLOURATION | 287 | 0.65% |
| VISUAL ACUITY REDUCED | 284 | 0.65% |
| TRICHORRHEXIS | 281 | 0.64% |
| BLEPHARAL PIGMENTATION | 278 | 0.63% |
| PNEUMONIA | 278 | 0.63% |
| DRUG DOSE OMISSION | 272 | 0.62% |
| VOMITING | 264 | 0.60% |
| ARTHRALGIA | 260 | 0.59% |
| PAIN IN EXTREMITY | 258 | 0.59% |
| COUGH | 255 | 0.58% |
| DRUG HYPERSENSITIVITY | 251 | 0.57% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 245 | 0.56% |
| WEIGHT DECREASED | 245 | 0.56% |
| INSOMNIA | 238 | 0.54% |
| PRODUCT QUALITY ISSUE | 235 | 0.53% |
| HYPERTENSION | 233 | 0.53% |
| EYE DISORDER | 217 | 0.49% |
| FOREIGN BODY SENSATION IN EYES | 208 | 0.47% |
| DECREASED APPETITE | 202 | 0.46% |
| BACK PAIN | 193 | 0.44% |
| BLOOD PRESSURE INCREASED | 191 | 0.43% |
| OCULAR DISCOMFORT | 190 | 0.43% |
| CONSTIPATION | 189 | 0.43% |
| PRODUCT PACKAGING QUANTITY ISSUE | 189 | 0.43% |
| HAIR GROWTH ABNORMAL | 188 | 0.43% |
| GAIT DISTURBANCE | 187 | 0.43% |
| ANAEMIA | 186 | 0.42% |
| ANXIETY | 180 | 0.41% |
| HYPOTENSION | 176 | 0.40% |
| CONDITION AGGRAVATED | 170 | 0.39% |
| PYREXIA | 170 | 0.39% |
| FEELING ABNORMAL | 166 | 0.38% |
| URINARY TRACT INFECTION | 165 | 0.38% |
| PHOTOPHOBIA | 164 | 0.37% |
| DEPRESSION | 155 | 0.35% |
| CONFUSIONAL STATE | 154 | 0.35% |
| SOMNOLENCE | 152 | 0.35% |
| EXPIRED PRODUCT ADMINISTERED | 151 | 0.34% |
| BLINDNESS | 150 | 0.34% |
| CHEST PAIN | 149 | 0.34% |
| PERIPHERAL SWELLING | 149 | 0.34% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.34% |
| ABDOMINAL DISCOMFORT | 146 | 0.33% |
| MYALGIA | 146 | 0.33% |
| OEDEMA PERIPHERAL | 146 | 0.33% |
| SWELLING OF EYELID | 146 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 145 | 0.33% |
| NASOPHARYNGITIS | 144 | 0.33% |
| EYELID PAIN | 143 | 0.33% |
| ATRIAL FIBRILLATION | 142 | 0.32% |
| ALOPECIA | 141 | 0.32% |
| WEIGHT INCREASED | 141 | 0.32% |
| BLEPHARITIS | 140 | 0.32% |
| BLOOD GLUCOSE INCREASED | 140 | 0.32% |
| BURNING SENSATION | 140 | 0.32% |
| Total | 43995 | |